These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 12697387)
1. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device. Cui Z; Baizer L; Mumper RJ J Biotechnol; 2003 Apr; 102(2):105-15. PubMed ID: 12697387 [TBL] [Abstract][Full Text] [Related]
2. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses. Cui Z; Mumper RJ Eur J Pharm Biopharm; 2003 Jan; 55(1):11-8. PubMed ID: 12551699 [TBL] [Abstract][Full Text] [Related]
3. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Mumper RJ; Cui Z Methods; 2003 Nov; 31(3):255-62. PubMed ID: 14511958 [TBL] [Abstract][Full Text] [Related]
4. Genetic immunization using nanoparticles engineered from microemulsion precursors. Cui Z; Mumper RJ Pharm Res; 2002 Jul; 19(7):939-46. PubMed ID: 12180545 [TBL] [Abstract][Full Text] [Related]
5. Topical immunization using nanoengineered genetic vaccines. Cui Z; Mumper RJ J Control Release; 2002 May; 81(1-2):173-84. PubMed ID: 11992690 [TBL] [Abstract][Full Text] [Related]
6. Low-volume jet injection for intradermal immunization in rabbits. Ren S; Li M; Smith JM; DeTolla LJ; Furth PA BMC Biotechnol; 2002 May; 2():10. PubMed ID: 12028591 [TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses. Cui Z; Mumper RJ J Pharm Pharmacol; 2002 Sep; 54(9):1195-203. PubMed ID: 12356273 [TBL] [Abstract][Full Text] [Related]
8. Chitosan-based nanoparticles for topical genetic immunization. Cui Z; Mumper RJ J Control Release; 2001 Aug; 75(3):409-19. PubMed ID: 11489327 [TBL] [Abstract][Full Text] [Related]
9. Intracellular targeting of CEA results in Th1-type antibody responses following intradermal genetic vaccination by a needle-free jet injection device. Johansson S; Ek M; Wahren B; Stout R; Liu M; Hallermalm K ScientificWorldJournal; 2007 Jun; 7():987-99. PubMed ID: 17619780 [TBL] [Abstract][Full Text] [Related]
10. Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses. Jiang J; Ramos SJ; Bangalore P; Fisher P; Germar K; Lee BK; Williamson D; Kemme A; Schade E; McCoy J; Muthumani K; Weiner DB; Humeau LM; Broderick KE Vaccine; 2019 Jun; 37(29):3832-3839. PubMed ID: 31174938 [TBL] [Abstract][Full Text] [Related]
11. Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation. Cui Z; Mumper RJ Bioconjug Chem; 2002; 13(6):1319-27. PubMed ID: 12440869 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Anwer K; Earle KA; Shi M; Wang J; Mumper RJ; Proctor B; Jansa K; Ledebur HC; Davis S; Eaglstein W; Rolland AP Pharm Res; 1999 Jun; 16(6):889-95. PubMed ID: 10397610 [TBL] [Abstract][Full Text] [Related]
13. Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. Cui Z; Patel J; Tuzova M; Ray P; Phillips R; Woodward JG; Nath A; Mumper RJ Vaccine; 2004 Jun; 22(20):2631-40. PubMed ID: 15193389 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration. Cherif MS; Shuaibu MN; Kurosaki T; Helegbe GK; Kikuchi M; Yanagi T; Tsuboi T; Sasaki H; Hirayama K Vaccine; 2011 Nov; 29(48):9038-50. PubMed ID: 21939717 [TBL] [Abstract][Full Text] [Related]
15. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Bråve A; Gudmundsdotter L; Sandström E; Haller BK; Hallengärd D; Maltais AK; King AD; Stout RR; Blomberg P; Höglund U; Hejdeman B; Biberfeld G; Wahren B Vaccine; 2010 Nov; 28(51):8203-9. PubMed ID: 20951666 [TBL] [Abstract][Full Text] [Related]
16. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice. Kawase A; Isaji K; Yamaoka A; Kobayashi N; Nishikawa M; Takakura Y Vaccine; 2006 Jul; 24(27-28):5535-45. PubMed ID: 16716462 [TBL] [Abstract][Full Text] [Related]
17. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Raz E; Tighe H; Sato Y; Corr M; Dudler JA; Roman M; Swain SL; Spiegelberg HL; Carson DA Proc Natl Acad Sci U S A; 1996 May; 93(10):5141-5. PubMed ID: 8643542 [TBL] [Abstract][Full Text] [Related]
18. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. Hartikka J; Bozoukova V; Ferrari M; Sukhu L; Enas J; Sawdey M; Wloch MK; Tonsky K; Norman J; Manthorpe M; Wheeler CJ Vaccine; 2001 Feb; 19(15-16):1911-23. PubMed ID: 11228361 [TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus. Hartikka J; Bozoukova V; Morrow J; Rusalov D; Shlapobersky M; Wei Q; Boutsaboualoy S; Ye M; Wloch MK; Doukas J; Sullivan S; Rolland A; Smith LR Hum Vaccin Immunother; 2012 Nov; 8(11):1595-606. PubMed ID: 22922766 [TBL] [Abstract][Full Text] [Related]
20. Delivery of immunoreactive antigen using a controllable needle-free jet injector. Hogan NC; Anahtar MN; Taberner AJ; Hunter IW J Control Release; 2017 Jul; 258():73-80. PubMed ID: 28479095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]